BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cross TJS, Villanueva A, Shetty S, Wilkes E, Collins P, Adair A, Jones RL, Foxton MR, Meyer T, Stern N, Warshow U, Khan N, Prince M, Khakoo S, Alexander GJ, Khan S, Reeves H, Marshall A, Williams R. A national survey of the provision of ultrasound surveillance for the detection of hepatocellular carcinoma. Frontline Gastroenterol 2016;7:82-9. [PMID: 28840911 DOI: 10.1136/flgastro-2015-100617] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Roskilly A, Rowe IA. Surveillance for hepatocellular cancer. Clin Med (Lond). 2018;18:s66-s69. [PMID: 29700096 DOI: 10.7861/clinmedicine.18-2-s66] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
2 Sagar VM, Herring K, Curbishley S, Hodson J, Fletcher P, Karkhanis S, Mehrzad H, Punia P, Shah T, Shetty S, Ma YT. The potential of PIVKA-II as a treatment response biomarker in hepatocellular carcinoma: a prospective United Kingdom cohort study. Oncotarget 2021;12:2338-50. [PMID: 34853657 DOI: 10.18632/oncotarget.28136] [Reference Citation Analysis]
3 Kelly D, Fernández-Ortega P, Arjona ET, Daniele B. The role of nursing in the management of patients with renal and hepatic cancers: A systematic literature review. Eur J Oncol Nurs 2021;55:102043. [PMID: 34655916 DOI: 10.1016/j.ejon.2021.102043] [Reference Citation Analysis]
4 Cargill Z, Brown SE, Dusheiko G, Agarwal K. Risk stratification in chronic hepatitis B patients for hepatocellular carcinoma surveillance: management in migrant sub-Saharan African populations. Gut 2021;70:629-30. [PMID: 32606207 DOI: 10.1136/gutjnl-2020-322181] [Reference Citation Analysis]
5 Williams R, Ashton K, Aspinall R, Bellis MA, Bosanquet J, Cramp ME, Day N, Dhawan A, Dillon J, Dyson J, Ferguson J, Foster G, Gilmore SI, Glynn M, Guthrie JA, Hudson M, Kelly D, Langford A, Newsome P, O'Grady J, Pryke R, Ryder S, Samyn M, Sheron N, Verne J. Implementation of the Lancet Standing Commission on Liver Disease in the UK. Lancet 2015;386:2098-111. [PMID: 26700394 DOI: 10.1016/S0140-6736(15)00680-7] [Cited by in Crossref: 38] [Cited by in F6Publishing: 19] [Article Influence: 5.4] [Reference Citation Analysis]
6 Goldsworthy MA, Fateen W, Thygesen H, Aldersley MA, Rowe IA, Jones RL. Patient understanding of liver cirrhosis and improvement using multimedia education. Frontline Gastroenterol 2017;8:214-9. [PMID: 28706622 DOI: 10.1136/flgastro-2016-100761] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
7 Taylor EJ, Rowe IA. Surveillance for Hepatocellular Carcinoma. In: Cross T, Palmer DH, editors. Liver Cancers. Cham: Springer International Publishing; 2019. pp. 13-21. [DOI: 10.1007/978-3-319-92216-4_2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]